Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease is a research paper published in European Journal of Neuroscience (2022). On theSindex it has a DataRank of 0. It has been cited 47 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Neurological Disorders and Stroke
Grant: U01NS093334
National Institutes of Health
Grant: R56AG062762
National Institute on Aging
Grant: P20AG068053
National Institute on Aging
Grant: R01AG053798
National Institute on Aging
Grant: R35AG71476
National Institute of General Medical Sciences
Grant: P20GM109025
NIA NIH HHS
Grant: R35 AG071476
NIA NIH HHS
Grant: P30 AG072980
National Institutes of Health
Grant: 5U01NS093334-02
Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors
National Institutes of Health
Grant: 5R35AG071476-02
Alzheimer's Clinical Trial InnOvatioN (ACTION) Initiative
National Institutes of Health
Grant: 1R56AG062762-01
Aging and hyperglycemia alter molecular mechanisms and hippocampal oscillations consistent with Alzheimer's disease
National Institutes of Health
Grant: 5R01AG053798-02
Global Alzheimer's Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease
National Institutes of Health
Grant: 5P20GM109025-03
COBRE GRANT
National Institutes of Health
Grant: 5P20AG068053-03
Nevada Exploratory Alzheimer's Disease Research Center (NVEADRC)
Alzheimer's Drug Discovery Foundation
FWCI
4.84
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals